Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Irani
Jean-Louis Davin

Showing results (71-80 of 150) with videos related to

Pageof 15
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 13, 2012
DNA-PKcs expression predicts response to radiotherapy in prostate cancerPatrick Bouchaert, Stephane Guerif, Celine Debiais, et al.
BJU International|October 12, 2013
Can we improve the definition of high-risk, hormone naïve, non-metastatic prostate cancer?Bertrand Tombal, Antonio Alcaraz, Nicholas James, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 22, 2004
[International comparison of guidelines for the management of benign prostatic hyperplasia: use of a validated generic tool]Jacques Irani, Christian Brown, Jan Van der Meulen, et al.
Annales De Pathologie|November 25, 2015
[Metastatic lymph node collision of a prostatic adenocarcinoma and an urothelial carcinoma and review of the literature]Audelaure Junca, Eric Frouin, Jacques Irani, et al.
The Lancet. Oncology|December 8, 2009
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trialJacques Irani, Laurent Salomon, Rostand Oba, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 23, 2005
[Standardized histopathology reports in urologic oncology]Marc de Fromont, Agnes Lesourd, Catherine Mazerolles, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 8, 2006
[Follow-up of prostate cancer. Guidelines of the Comité de Cancérologie de l'Association Française d'Urologie]Pierre Richaud, Jean-Luc Moreau, Philippe Beuzeboc, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 28, 2003
[Hyperbaric oxygen therapy and radiation-induced hemorrhagic cystitis]Christophe Pires, Jacques Irani, Frédéric Ouaki, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 6, 2004
[Management of bladder cancer associated with prostate cancer]Jean-Louis Bonnal, Jacques Irani, Marc Maidenberg, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 3, 2003
[Partial infarction of the kidney caused by spontaneous idiopathic dissection of the renal artery]Laurent Dahmani, François-Joseph Murat, Frédéric Ouaki, et al.
Pageof 15

Showing results (71-80 of 150) with videos related to

Sort By:
Pageof 15
International Journal of Radiation Oncology, Biology, Physics|April 13, 2012
DNA-PKcs expression predicts response to radiotherapy in prostate cancerPatrick Bouchaert, Stephane Guerif, Celine Debiais, et al.
BJU International|October 12, 2013
Can we improve the definition of high-risk, hormone naïve, non-metastatic prostate cancer?Bertrand Tombal, Antonio Alcaraz, Nicholas James, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 22, 2004
[International comparison of guidelines for the management of benign prostatic hyperplasia: use of a validated generic tool]Jacques Irani, Christian Brown, Jan Van der Meulen, et al.
Annales De Pathologie|November 25, 2015
[Metastatic lymph node collision of a prostatic adenocarcinoma and an urothelial carcinoma and review of the literature]Audelaure Junca, Eric Frouin, Jacques Irani, et al.
The Lancet. Oncology|December 8, 2009
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trialJacques Irani, Laurent Salomon, Rostand Oba, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 23, 2005
[Standardized histopathology reports in urologic oncology]Marc de Fromont, Agnes Lesourd, Catherine Mazerolles, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 8, 2006
[Follow-up of prostate cancer. Guidelines of the Comité de Cancérologie de l'Association Française d'Urologie]Pierre Richaud, Jean-Luc Moreau, Philippe Beuzeboc, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 28, 2003
[Hyperbaric oxygen therapy and radiation-induced hemorrhagic cystitis]Christophe Pires, Jacques Irani, Frédéric Ouaki, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 6, 2004
[Management of bladder cancer associated with prostate cancer]Jean-Louis Bonnal, Jacques Irani, Marc Maidenberg, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 3, 2003
[Partial infarction of the kidney caused by spontaneous idiopathic dissection of the renal artery]Laurent Dahmani, François-Joseph Murat, Frédéric Ouaki, et al.
Pageof 15